Clinical Trial Update: A Randomized, Double-Blind, Parallel Group, Placebo-Controlled Study to Assess STS101 in the Acute Treatment of Migraine [Phase 3]

View source ↗

Summary

A Phase 3 randomized, double-blind, placebo-controlled trial evaluating STS101 for acute treatment of migraine, with completed status and results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine
• Migraine Without Aura
• Migraine with Aura

Drugs mentioned

• STS101 (STS101)

Snippet

Sponsor: Satsuma Pharmaceuticals, Inc. | Conditions: Migraine, Migraine With Aura | Phase 3 | Status: COMPLETED | Results posted: 2023-07-24